Tamper Evident Caps
Featuring RFID Technology
The Use of Radio Frequency Identification (RFID) in Pharmacy
Radio Frequency Identification ( RFID ) continues to gain rapid popularity in Healthcare, and rightfully so. The technology enables real time scanning that optimizes inventory management, efficiency, and medication safety while creating quantifiable pharmaceutical supply chain benefits by providing item level inventory visibility down to National Drug Code (NDC) and Lot. IMI has partnered with DoseID (see full press release here) to increase interoperablitiy, quality and performance of RFID tagged product for Healthcare Professionals.
Comprehensive Diversion Prevention
Where there are drugs, there will always be attempts at diversion.
Prep-Lock™ Tamper Evident Caps for IV Syringes are an active deterrent to drug diversion and misuse. Applied by the pharmacist, once installed Tamper Evident Caps cannot be removed without clear evidence of access or misuse. Built-in RFID technology takes tracking and serialization beyond DSCSA (Drug Supply Chain Security Act) recommendations and requirements. It uniquely serialized every dose, from the unit of sale to the unit of use. Every drug secured with Tamper Evident RFID technology is trackable throughout its entire lifecycle. Visibility throughout the medication supply chain allows facilities to identify anomalous usage, assess risks, and utilize actionable data to comply with growing regulatory demands, just to name a few. These two powerful technologies in combination enhance workflow efficiencies, eliminate time-consuming manual inventory control processes, provide assistance with growing regulatory demand, and supply a comprehensive strategy to prevent, detect, and resolve drug diversion events. In addition, by incorporating RFID technology into IMI’s Industry-leading Tamper Evident Caps, facilities can reduce their cost of RFID implementation by up to 55% with little time-to-live and minimal staff investment, procedural changes, or capital investment.
Save up to 55%
By incorporating RFID technology into IMI’s Industry-leading Prep-Lock Tamper Evident Caps, facilities can reduce their cost of RFID implementation by up to 55% with little time-to-live, minimal staff investment, procedural changes, or capital investment.
Simplify Labor Intensive Processes
Reduce medication restocking by 72 – 96% and support multiple pharmacy workflows.
Reduce Drug Shortages
Incorporated RFID technology improves restocking efficiencies with automation, allows for on-demand reporting for identification of upcoming expirations, and reduces inventory visibility gaps.
Prevent Diversion Events
Tamper Evident Caps equipped with RFID Technology actively deter diversion by providing a physical barrier and powerful analytic capabilities to your drugs at product level.
Traceability & Visibility
DoseID takes serialization from the unit of sale to the unit of use. It uniquely serializes every dose to track each action taken upon it during its entire life cycle and ensure RFID Tagged drugs work in all downstream IT systems in hospitals and health systems.
The Benefits of Tamper Evident Caps Equiped with RFID
Drug shortages remain a primary concern for Pharmacists. According to a recent survey of 238 Pharmacy Leaders, 66% of are currently experiencing shortages of up to 20 drugs. These shortages not only jeopardize patient care, they also represent costly financial implications for institutions and an allocation of valuable, and often scarce, resources. 62% said handling each shortage consumed at least 10 staff hours. A survey of health system pharmacies in the southeastern U.S. found alternatives to hard to find medications marked up by 300 – 500%. Premier Healthcare Alliance estimates the costs to find suitable substitutions for unavailable drugs to have inflated hospital costs by $200 million annually. Prep-Lock™ Tamper Evident Caps with RFID improves restocking efficiencies with automation, allows for on-demand reporting for identification of upcoming expirations, and reduces inventory visibility gaps.
Facilities are also beginning to acknowledge the prevalence of diversion in Healthcare, and the importance of a comprehensive strategy to prevent, detect and rectify diversion events. A staggering 37% of pharmacists are aware of a colleague who has diverted opioids. Because diversion can occur at any point of the supply chain, visibility and security are paramount. Tamper Evident Caps with RFID provide a robust solution by providing both a physical barrier and Syringe-level visibility. IMI has been developing diversion mitigating devices for over half a century. Tamper Evident Caps equipped with RFID Technology actively deter diversion by providing a physical barrier and powerful analytic capabilities to your drugs at the product level. For more on how Tamper Evident Caps with RFID can help you increase patient care, optimize operational efficiencies, and enhance your drug security program download our whitepaper.
IMI (International Medical Industries, Inc.) bolsters expertise in secure drug delivery products with the release of their Prep-Lock Tamper Evident Cap for IV Syringes with incorporated Radio Frequency Identification (RFID) technology.
The Staggering Cost of DiversionA recent study published in the Journal of Hospital Medicine cited the vast costs diversion poses for Health Systems. “Hospitals bear the cost of diverted drugs, internal investigations, and follow-up care for affected patients, and can...
The Substance Abuse and Mental Health Services Administration and American Nurses Association estimate that 10% of health care workers experience substance abuse, given the access to medications in health care institutions. One report estimates that, in 2019, 148 million medication doses were diverted by health care employees.
Find out more about how Tamper Evident Caps with RFID can improve the safety and efficiency of your Pharmacy operation. Fill out the form below and one of our Specialists will get back to you as soon as possible (usually within one business day). For immediate assistance between 9 am – 4:30 pm (EST) call 800-344-2554.
You May Also Be Interested In
IMI remains at the forefront of developing new products specifically designed for the compounding industry. Our strategic partnerships with some of the biggest names in healthcare enable us to continuously deliver the kind of high-quality and high-value products that pharmacy operations demand. All IMI products are manufactured in the United States under the strictest quality standards at our FDA-registered, ISO 13485–certified facility. Browse our comprehensive product families below, and as always our premium products are back with premium service. If you have any questions, contact us, we’re here to help!
1.) Caulder CR, Mehta B, Bookstaver PB, Sims LD, Stevenson B; South Carolina Society of Health-System Pharmacists. Impact of drug shortages on health system pharmacies in the south eastern United States. Hosp Pharm. 2015;50(4):279-286. 2.) Cherici C, Frazier J, Feldman M, et al. Navigating drug shortages in American healthcare: a premier healthcare alli ance analysis. https://www.heartland.org/_template-assets /documents/publications/30103.pdf. Published March 2011. Accessed December 5, 2017. 3.) The 2019 State of Hospital Pharmacy Operations https://kitcheck.com/wp-content/uploads/2020/04/Hospital-Pharmacy-Operations-Report-2019-Kit-Check.pdf